Provided by Tiger Trade Technology Pte. Ltd.

BriaCell Therapeutics Corp.

4.07
+0.14003.56%
Post-market: 4.01-0.0600-1.47%19:30 EDT
Volume:150.44K
Turnover:612.48K
Market Cap:35.41M
PE:-0.42
High:4.18
Open:3.99
Low:3.97
Close:3.93
52wk High:14.68
52wk Low:2.60
Shares:8.70M
Float Shares:7.86M
Volume Ratio:1.01
T/O Rate:1.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.6592
EPS(LYR):-62.1862
ROE:-175.25%
ROA:-90.84%
PB:1.47
PE(LYR):-0.07

Loading ...

BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer

GlobeNewswire
·
Aug 05

Source Rock Royalties Declares Monthly Dividend and Grants New RSUs

TIPRANKS
·
Jul 16

BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer

GlobeNewswire
·
Jul 16

BriaCell arranges scalable manufacturing with Fujifilm Biotechnologies

TIPRANKS
·
Jul 15

BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™

GlobeNewswire
·
Jul 15

BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™

GlobeNewswire
·
Jul 07

BriaCell Subsidiary Highlights Interim Results, Ongoing Losses

TIPRANKS
·
Jun 27

BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™

GlobeNewswire
·
Jun 25

BriaCell Therapeutics Q3 EPS $(0.99) Up From $(16.40) YoY

Benzinga Earnings
·
Jun 10

BriaCell Therapeutics Completes Equity Offering to Fund Operations

TIPRANKS
·
Jun 03

BriaCell Therapeutics Closes $4.7 Million Share Offering

MT Newswires Live
·
Jun 03

BriaCell Therapeutics Announces Closing of Offering

GlobeNewswire
·
Jun 03

BriaCell Presents Positive Clinical Data at ASCO 2026

GlobeNewswire
·
Jun 01

BriaCell Therapeutics Prices $4.7 Million Share Offering

MT Newswires Live
·
Jun 01

BriaCell Therapeutics Announces Pricing of Offering

GlobeNewswire
·
Jun 01

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

GlobeNewswire
·
May 26

BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026

GlobeNewswire
·
May 22

BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™

GlobeNewswire
·
May 15

BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer

GlobeNewswire
·
May 14

BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

GlobeNewswire
·
May 13